Activated sub-populations of lymphocytes and natural killer cells in normal liver and liver grafts before transplantation

Liver. 1998 Aug;18(4):259-63. doi: 10.1111/j.1600-0676.1998.tb00163.x.

Abstract

Aims/background: The anatomic structure of the liver suggests that it is a place of intense trafficking between intra-hepatic and peripheral blood compartment leukocytes. Furthermore, the liver contains a large number of passenger leukocytes that may play a role in the appearance of donor-type microchimerism after transplantation. In this study, we aimed to define the principal lymphocyte sub-populations contained in donor peripheral blood and liver grafts and in normal liver removed during minimally invasive surgery.

Methods: Liver biopsies were taken at the time of vascular clampage during liver extraction from donors in a brain dead state (GI: n=14). Normal liver biopsies were removed during minimaly invasive surgery (GII: n= 10).

Results: We observed evidence of the presence of lymphocytic activation associated with the two major CD8+ lymphocyte and natural killer (NK) cell populations in the two groups, with a significant increase in TCRgammadelta-bearing lymphocyte receptors between normal liver and the liver graft.

Conclusions: The presence of activated leukocytes in the graft could have a fundamental role in induction of peripheral tolerance. This activation could be the result of a basic immunological response linked to the interaction of T cells and NK cells, and of secondary activation due to stress and the conditions necessary for organ removal from donors in a brain dead state.

MeSH terms

  • Adult
  • Animals
  • Antibodies, Monoclonal
  • Female
  • Graft Survival / immunology
  • Humans
  • Immunophenotyping
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / pathology
  • Liver / immunology*
  • Liver / pathology
  • Liver Transplantation / immunology*
  • Lymphocyte Activation*
  • Lymphocyte Subsets / immunology*
  • Lymphocyte Subsets / pathology
  • Male
  • Mice
  • Transplantation, Homologous

Substances

  • Antibodies, Monoclonal